Tetra Bio-Pharma Inc. (TBPMQ)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Jan 21, 2026, 9:30 AM EST
Tetra Bio-Pharma Market Cap
Tetra Bio-Pharma has a market cap or net worth of $516 as of January 23, 2026. Its market cap has decreased by -99.99% in one year.
Market Cap
516.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 25, 2015, Tetra Bio-Pharma's market cap has decreased from 910.80K to 516.00, a decrease of -99.94%. That is a compound annual growth rate of -49.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 516.00 | - |
| Dec 30, 2025 | 516.00 | - |
| Dec 31, 2024 | 516.00 | -99.83% |
| Dec 29, 2023 | 309.38K | -96.57% |
| Dec 30, 2022 | 9.02M | -76.93% |
| Dec 31, 2021 | 39.11M | -8.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| eFFECTOR Therapeutics | 941.00 |
| Pathfinder Cell Therapy | 667.00 |
| U.S. Stem Cell | 662.00 |
| Amarantus BioScience Holdings | 630.00 |
| GlobeImmune | 575.00 |
| RegeneRx Biopharmaceuticals | 453.00 |
| Eloxx Pharmaceuticals | 330.00 |
| Nabriva Therapeutics | 323.00 |